What drugs does ESJAY PHARMA make?

ESJAY PHARMA has 5 FDA-approved drugs.

What therapeutic areas does ESJAY PHARMA focus on?

ESJAY PHARMA focuses primarily on Metabolic and Infectious Disease and 1 other therapeutic areas.

← Back

Data updated: Mar 10, 2026

ESJAY PHARMA

MetabolicInfectious DiseaseNeurology

Big Pharma

ESJAY PHARMA is a major pharmaceutical company focused on Metabolic, Infectious Disease, Neurology.

1941

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

FUROSEMIDE 2026-01-08

FUROSEMIDE 2025-09-12

Labeling

FUROSEMIDE 2025-09-08

Labeling

FUROSEMIDE 2025-08-06

Labeling

FUROSEMIDE 2025-07-17

FUROSEMIDE 2025-05-08

Labeling

FUROSEMIDE 2024-12-13

FUROSEMIDE 2024-10-01

Labeling

FUROSEMIDE 2024-10-01

Labeling

FUROSEMIDE 2024-10-01

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 50%

2 drugs

Infectious Disease 25%

1 drugs

Neurology 25%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Novo Nordisk big-pharma

Metabolic, Infectious Disease, Neurology

AZURITY specialty

Neurology, Metabolic, Infectious Disease

ABBOTT big-pharma

Infectious Disease, Neurology, Metabolic

Merck big-pharma

Infectious Disease, Metabolic

AbbVie big-pharma

Neurology, Infectious Disease

ESJAY PHARMA

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (5)

Active (4)

Discontinued (1)

Company Info